| 杨兰艳,殷芳,王建刚,等.肿瘤坏死因子受体相关因子 6的表达对食管鳞状细胞癌预后的影响[J].安徽医药,2020,24(6):1195-1198. |
| 肿瘤坏死因子受体相关因子 6的表达对食管鳞状细胞癌预后的影响 |
| Effect of TRAF6 expression on the prognosis of esophageal squamous cell carcinoma |
| |
| DOI：10.3969/j.issn.1009?6469.2020.06.034 |
| 中文关键词: 食管肿瘤 肿瘤坏死因子受体相关因子 6 复发 生存 |
| 英文关键词: Esophageal neoplasms Tumor necrosis factor receptor?related factor 6 Recurrence Survival |
| 基金项目: |
|
| 摘要点击次数: 1600 |
| 全文下载次数: 499 |
| 中文摘要: |
| 目的探讨肿瘤坏死因子受体相关因子 6(TRAF6)在食管鳞状细胞癌( ESCC)组织中的表达与复发和生存的关系。方法选取 2012年 12月至 2014年 2月在云南省第三人民医院接受根治性切除术治疗的经病理证实为 ESCC的病人 478例作为研究对象。采用免疫组织化学法检测 ESCC病人癌组织中 TRAF6的表达。并探讨 TRAF6的表达与 ESCC病人复发和生存的相关性。结果 478例 ESCC病人中， 341例( 71.3％)符合 TRAF6表达阳性标准。 TRAF6表达与性别、年龄、肿瘤大小无关(P＞0.05)但是与 ESCC病人的 TNM分期、淋巴结转移、复发和死亡状况显著相关( P＜0.05)。淋巴结转移、较高临床分期、发生复发或死，亡的病人 TRAF6阳性表达率高。进一步分析发现， TRAF6阳性表达的 ESCC病人复发和死亡风险增加［ HR(95%CI):2.47(1.63~3.84)，3.05(2.37~3.48)］。结论 TRAF6在 ESCC癌组织中的表达参与 ESCC的发生发展， TRAF6表达阳性病人复发和死亡的风险增加； TRAF6可作为 ESCC潜在的治疗靶点。 |
| 英文摘要: |
| Objective To investigate the relationship between tumor necrosis factor receptor associated factor 6(TRAF6)expres? sion and the recurrence and survival in patients with esophageal squamous cell carcinoma(ESCC).Methods A total of 478 pa? tients pathologically confirmed with ESCC who underwent radical resection in The Third People’s Hospital of Yunnan Provincefrom December 2012 to February 2014 were included as the research subjects.The expression of TRAF6 in cancer tissues of ESCCpatients was evaluated by immunohistochemistry.The relationship between the expression of TRAF6 and the recurrence and survivalof ESCC patients were investigated.Results Among the 478 ESCC patients，341(71.3%)met the TRAF6 positive expression crite? ria.TRAF6 expression was not associated with gender，age，and tumor size(P＞0.05)，but was significantly associated with TNM stage，lymph node metastasis，recurrence，and death status in ESCC patients(P＜0.05).Patients with lymph node metastasis，higherclinical stage，and recurrence or death，have a high rate of TRAF6 positive expression.Further analysis suggested an increased riskof recurrence and death in ESCC patients showing positive TRAF6 expression［HR(95%CI):2.47(1.63?3.84)，3.05(2.37?3.48)］. Conclusions The expression of TRAF6 in ESCC cancer tissues is involved in the development of ESCC.The risk of recurrenceand death is increased in patients with positive TRAF6 expression.TRAF6 can be used as a potential therapeutic target for ESCC. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
